Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.810,68
2,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Veracyte Inc (VCYT) Veracyte Inc (VCYT) Notizie

Veracyte Inc

VCYT
22,73
-0,67 (-2,86%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:30:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202423:04BWVeracyte to Participate in Upcoming Investor Conferences
08/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:10EDGAR2Form 8-K - Current report
07/5/202422:05BWVeracyte Announces First Quarter 2024 Financial Results
06/5/202422:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
22/4/202423:00BWVeracyte to Release First Quarter 2024 Financial Results on..
22/4/202414:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
16/4/202414:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:27EDGAR2Form 8-K - Current report
29/2/202423:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
29/2/202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/2/202414:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202423:55BWVeracyte’s Decipher Prostate Test Receives Highest..
22/2/202422:12EDGAR2Form 8-K - Current report
22/2/202422:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
21/2/202423:00BWVeracyte to Participate in the Raymond James 45th Annual..
13/2/202422:15EDGAR2Form 8-K - Current report
08/2/202414:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
06/2/202414:23EDGAR2Form 8-K - Current report
06/2/202414:15BWVeracyte Completes Acquisition of C2i Genomics
29/1/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:12EDGAR2Form 8-K - Current report
08/1/202414:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..
12/12/202322:30BWVeracyte to Participate in the 42nd Annual J.P. Morgan..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:05BWReal-World Data Presented at SUO 2023 Show that Veracyte’s..
29/11/202314:30BWClinical Validation Data Published in CHEST Demonstrate that..
22/11/202314:30BWVeracyte Announces Seven Posters Highlighting Clinical Value..
08/11/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:09EDGAR2Form 8-K - Current report
07/11/202322:05BWVeracyte Announces Third Quarter 2023 Financial Results
07/11/202322:00BWVeracyte Announces In Vitro Diagnostic Agreement with..
02/11/202313:15BWVeracyte to Participate in the Stephens Annual Investment..
27/10/202314:30BWVeracyte Announces SITC 2023 Presentations Offering New..
Apertura: 23,44 Min: 22,85 Max: 23,47
Chiusura: 23,40

La tua Cronologia

NASDAQ
VCYT
Veracyte
LSE
LARD
Laird
DBI
4J0T
DAX PR CZK
UPBT
IGNISKRW
Ignis
ASX
JBY
James Bay Minerals
TSX
MWD
Mackenzie Maximum Divers...
LSE
67FF
Euro.bk. 24
USOTC
ZHEC
ZHRH (CE)
LSE
SCNA
COIN
ACUST
ACoconut
XE
ABIE
Axa IM ETF ICAV
XE
DAR
Datron
LSE
BREE
Breedon
FX
TRYSEK
TRY vs SEK
NASDAQ
HAWK
BLACKHAWK NETWORK HOLDINGS, INC
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network